TipRanks
20/20 Biolabs, Inc. (AIDX)
NASDAQ:AIDX
US Market
AIDX
20/20 Biolabs, Inc.
RESEARCH TOOLSreports
Want to see AIDX full AI Analyst Report?

20/20 Biolabs, Inc. (AIDX) Income Statement

13 Followers

20/20 Biolabs, Inc. Income Statement

Last quarter (Q2 2026), 20/20 Biolabs, Inc.'s total revenue was $730.57K, an increase of 36.28% from the same quarter last year. In Q2, 20/20 Biolabs, Inc.'s net income was $-1.51M. See 20/20 Biolabs, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.05M$ 1.75M$ 1.42M$ 11.06M$ 9.62M
Gross Profit
$ 604.54K$ 360.31K$ 109.14K$ 5.12M$ 4.69M
Operating Expenses
$ 3.94M$ 6.02M$ 6.47M$ 3.44M$ 2.75M
Depreciation and Amortization
$ 77.98K$ 135.76K$ 167.29K$ 288.69K$ 123.66K
EBITDA
$ -3.50M$ -5.53M$ -6.19M$ 1.97M$ 2.07M
Operating Income
$ -3.33M$ -5.66M$ -6.36M$ 1.68M$ 1.94M
Other Income/Expenses
$ -407.95K$ 109.39K$ -29.85K$ 508.01K$ 129.68K
Pretax Income
$ -3.74M$ -5.55M$ -6.39M$ 2.19M$ 2.07M
Net Income
$ -3.74M$ -5.55M$ -6.39M$ 2.19M$ 2.07M
Per Share Metrics
Basic EPS
$ -0.60$ -1.16$ -1.34$ 0.46$ 0.44
Diluted EPS
$ -0.60$ -1.16$ -1.34$ 0.23$ 0.22
Weighted Average Shares Outstanding
 6.26M 4.80M 4.77M 4.76M 4.73M
Weighted Average Shares Outstanding (Diluted)
 6.26M 4.80M 4.77M 9.49M 9.46M
Currency in USD

20/20 Biolabs, Inc. Earnings and Revenue History